EichorEICHOR
Location: Halifax Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Halifax

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Centre of Applied Urology Research/Nova Scotia Health Author · Pfizer · NCT07028853Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis
Phase 1 · Canadian Center for Vaccinology · Dalhousie University · NCT06827470Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · QEII Health Sciences Centre - Victoria General Site ( Site 0 · Merck Sharp & Dohme LLC · NCT06393374MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · QEII Health Sciences Centre/Nova Scotia Health Authority · National Cancer Institute (NCI) · NCT05564390A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · IWK Health Centre · National Cancer Institute (NCI) · NCT05099003Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · IWK Health Centre · National Cancer Institute (NCI) · NCT06172296Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · NRG Oncology · NCT05624996Carotid Intraplaque Neovascularization Combined With Stress Echo
Phase N/A · Dalhousie University · Dr. Amer Johri · NCT0541638590Yttrium Colloid for the Treatment of Cystic Sellar/Parasellar Tumors
Phase 3 · Halifax Infirmary · David Clarke · NCT02081768UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · IWK Health Centre · The Hospital for Sick Children · NCT06560606Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Izaak Walton Killam (IWK) Health Center · PedAL BCU, LLC · NCT05183035A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · IWK Health Centre · Children's Oncology Group · NCT06368817A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · IWK Health Centre · National Cancer Institute (NCI) · NCT05691478Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery
Phase 2 · IWK Health Sciences Center · IWK Health Centre · NCT06357234LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · QEII Health Sciences Centre - Victoria General Site · Eli Lilly and Company · NCT07415044A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Nova Scotia Cancer Centre ( Site 0617) · Merck Sharp & Dohme LLC · NCT07216703Essential Coaching Postpartum: Evaluating a Parent-focused Postpartum Text Message Program in Nova Scotia
NA · IWK Health · IWK Health Centre · NCT06996067The Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting
NA · Dalhousie University · Université de Sherbrooke · NCT07396857A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide
Phase 1/Phase 2 · QEII Health Sciences Centre - Victoria General Site · Celgene · NCT06988488MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Agendia · NCT03053193Selinexor and Backbone Treatments of Multiple Myeloma Patients
Phase 1/Phase 2 · Queen Elizabeth II Health Sciences Center · Karyopharm Therapeutics Inc · NCT02343042A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · IWK Health Centre · Children's Oncology Group · NCT04322318Exercise for Oncology Care Professionals
NA · Physical Activity and Cancer (PAC) Lab · Melanie Keats · NCT05884073Cardiac Sarcoidosis Multi-Center Prospective Cohort
Phase N/A · QEII Health Sciences Center · Ottawa Heart Institute Research Corporation · NCT01477359Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial
Phase 4 · Nova Scotia Health · Nova Scotia Health Authority · NCT06093126A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Centricity Research Halifax Multispecialty · Bristol-Myers Squibb · NCT06976216Brain Imaging Study on Biomarkers for Fibromyalgia
NA · Nova Scotia Health Authority · Nova Scotia Health Authority · NCT03910010Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · Research Site · AstraZeneca · NCT06465810
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.